Novavax shares are trading lower by 9.8% during Monday’s session. Shares of vaccine stocks are trading lower after Moderna issued 2025 revenue guidance below analyst estimates.
Why Novavax (NVAX) Stock Is Falling
Where Today's News Shapes Tomorrow
